Related Experiment Video

Updated: Jul 10, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Management of neonatal and infancy-onset diabetes mellitus

Oddmund Søvik1, Mojca Zerjav Tansek, Jørn V Sagen

  • 1Department of Clinical Medicine, University of Bergen, Norway.

Endocrine Development
|November 8, 2007
PubMed

Insights

Early molecular genetic diagnosis is crucial for rare pediatric diabetes mellitus, enabling targeted treatments like oral sulfonylureas for specific genetic defects and improving patient outcomes.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Diabetes mellitus in the first two years of life is rare, accounting for 3-5% of childhood cases.
  • This age group presents unique diagnostic, treatment, and psychosocial challenges.
  • Early identification is vital due to the vulnerability of young patients.

Purpose of the Study:

  • To highlight the importance of early molecular genetic diagnosis in pediatric diabetes.
  • To discuss advancements in diagnosis and classification of neonatal diabetes.
  • To emphasize the need for comorbidity screening and psychosocial support.

Main Methods:

  • Review of current diagnostic and classification approaches for pediatric diabetes.
  • Emphasis on molecular genetic testing for specific gene defects (e.g., KCNJ11, ABCC8, GCK).
  • Discussion of treatment strategies, including oral sulfonylureas for specific genetic mutations.

Main Results:

  • Molecular genetic diagnosis allows for tailored treatments, such as oral sulfonylureas for Kir6.2 and SUR1 defects.
  • Differentiation between transient and permanent neonatal diabetes requires long-term follow-up.
  • Comorbidities like celiac disease and Wolcott-Rallison syndrome should be screened for.

Conclusions:

  • Early molecular genetic diagnosis is essential for optimizing treatment and outcomes in pediatric diabetes.
  • Type 1 diabetes is the most common subtype after the first year of life.
  • Infant insulin treatment and family psychosocial support are critical components of care.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...